PULNOVO
PrivateLast Round
Series D
Apr 19, 2026
Total Funding Raised
$215.4M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PULNOVO operates in Healthcare & Life Sciences and is based in Wuxi. Its latest recorded funding round was a Series D round in April 2026.
Pulnovo Medical is a medical technology company that develops and manufactures interventional therapies, including its proprietary Pulmonary Artery Denervation (PADN) system, for the treatment of pulmonary hypertension and heart failure.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PULNOVO Comparables
Compare PULNOVO with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Gradient Denervation Technologies | 84% | |
| Adona Medical | 79% | |
| Ablative Solutions | 78% |
For institutional investors. Book with your work email.
PULNOVO Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series D | Apr 19, 2026 | ||||
| Series C | Mar 2, 2025 | ||||
| Series B | Nov 7, 2022 | ||||
| Series A | Aug 4, 2021 |
For institutional investors. Book with your work email.
PULNOVO Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| YuanBio Venture Capital | Series B |
| OrbiMed | Series B, Series D, Series C, Series A |
| EQT AB | Series D |
| Cenova Capital | Series B, Series A |
| Lilly Asia Ventures | Series A, Series B, Series D, Series C |
| Qiming Venture Partners | Series D, Series C |
| HongShan Capital Group (HSG) | Series D |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 19, 2026
$100M round led by Medtronic
- Mar 2, 2025
$100M round led by Lilly Asia Ventures and Qiming Venture Partners.
For institutional investors. Book with your work email.
PULNOVO Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PULNOVO's valuation, stock price, and market status.
Is PULNOVO a public or private company?
PULNOVO is a private company.
What is the current stock price of PULNOVO?
PULNOVO is a private company, so its shares have no public market price. Caplight tracks PULNOVO's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PULNOVO worth (valuation)?
Valuation information for PULNOVO is not publicly available.
Can I buy PULNOVO stock?
PULNOVO shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PULNOVO's last funding round?
PULNOVO's most recent funding round was Series D on April 19, 2026.
Who are the main investors in PULNOVO?
Key investors in PULNOVO include YuanBio Venture Capital, OrbiMed, Cenova Capital, Lilly Asia Ventures, Qiming Venture Partners.
Will PULNOVO IPO soon?
No public IPO plans have been announced for PULNOVO.
How can I track PULNOVO secondary market activity?
Caplight tracks bids, offers, and trades in PULNOVO's shares on secondary markets.